Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Upgrades
MoffettNathanson upgraded the previous rating for Zoom Video Communications Inc (NASDAQ:ZM) from Underperform to Market Perform. Zoom Video Comms earned $1.16 in the first quarter, compared to $1.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $124.05 and a 52-week-low of $60.45. Zoom Video Comms closed at $71.41 at the end of the last trading period.
Evercore ISI Group upgraded the previous rating for CCC Intelligent Solutions Holdings Inc (NASDAQ:CCCS) from In-Line to Outperform. For the first quarter, CCC Intelligent Solutions had an EPS of $0.07, compared to year-ago quarter EPS of $0.08. The current stock performance of CCC Intelligent Solutions shows a 52-week-high of $10.19 and a 52-week-low of $8.20. Moreover, at the end of the last trading period, the closing price was at $9.92.
According to HSBC, the prior rating for Chevron Corp (NYSE:CVX) was changed from Hold to Buy. For the first quarter, Chevron had an EPS of $3.55, compared to year-ago quarter EPS of $3.36. At the moment, the stock has a 52-week-high of $189.66 and a 52-week-low of $132.54. Chevron closed at $152.44 at the end of the last trading period.
According to Goldman Sachs, the prior rating for Quanterix Corp (NASDAQ:QTRX) was changed from Neutral to Buy. For the first quarter, Quanterix had an EPS of $0.16, compared to year-ago quarter EPS of $0.49. At the moment, the stock has a 52-week-high of $20.20 and a 52-week-low of $6.32. Quanterix closed at $19.23 at the end of the last trading period.
For Myriad Genetics Inc (NASDAQ:MYGN), Goldman Sachs upgraded the previous rating of Sell to Buy. Myriad Genetics earned $0.21 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $28.17 and a 52-week-low of $13.92. At the end of the last trading period, Myriad Genetics closed at $20.07.
For Greenhill & Co Inc (NYSE:GHL), Keefe, Bruyette & Woods upgraded the previous rating of Underperform to Market Perform. Greenhill & Co earned $1.27 in the first quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Greenhill & Co shows a 52-week-high of $14.85 and a 52-week-low of $5.70. Moreover, at the end of the last trading period, the closing price was at $14.66.
See all analyst ratings upgrades.
Downgrades
For Rain Oncology Inc (NASDAQ:RAIN), Citigroup downgraded the previous rating of Buy to Neutral. Rain Oncology earned $0.56 in the first quarter, compared to $0.66 in the year-ago quarter. The stock has a 52-week-high of $14.48 and a 52-week-low of $1.11. At the end of the last trading period, Rain Oncology closed at $1.22.
Citigroup downgraded the previous rating for Integra Lifesciences Holdings Corp (NASDAQ:IART) from Neutral to Sell. For the first quarter, Integra Lifesciences had an EPS of $0.74, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $62.94 and a 52-week-low of $40.68. At the end of the last trading period, Integra Lifesciences closed at $50.72.
Piper Sandler downgraded the previous rating for VectivBio Holding AG (NASDAQ:VECT) from Overweight to Neutral. None
For VectivBio Holding AG (NASDAQ:VECT), SVB Leerink downgraded the previous rating of Outperform to Market Perform. None
For Maravai LifeSciences Holdings Inc (NASDAQ:MRVI), Credit Suisse downgraded the previous rating of Outperform to Neutral. In the first quarter, Maravai LifeSciences showed an EPS of $0.03, compared to $0.54 from the year-ago quarter. The current stock performance of Maravai LifeSciences shows a 52-week-high of $35.82 and a 52-week-low of $11.89. Moreover, at the end of the last trading period, the closing price was at $13.60.
According to Needham, the prior rating for Intercept Pharmaceuticals Inc (NASDAQ:ICPT) was changed from Buy to Hold. For the first quarter, Intercept Pharma had an EPS of $0.77, compared to year-ago quarter EPS of $0.58. The stock has a 52-week-high of $21.86 and a 52-week-low of $9.21. At the end of the last trading period, Intercept Pharma closed at $9.53.
RBC Capital downgraded the previous rating for Wheaton Precious Metals Corp (NYSE:WPM) from Outperform to Sector Perform. In the first quarter, Wheaton Precious Metals showed an EPS of $0.23, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $52.76 and a 52-week-low of $28.63. At the end of the last trading period, Wheaton Precious Metals closed at $47.79.
JonesTrading downgraded the previous rating for Rain Oncology Inc (NASDAQ:RAIN) from Buy to Hold. In the first quarter, Rain Oncology showed an EPS of $0.56, compared to $0.66 from the year-ago quarter. The stock has a 52-week-high of $14.48 and a 52-week-low of $1.11. At the end of the last trading period, Rain Oncology closed at $1.22.
For Rain Oncology Inc (NASDAQ:RAIN), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the first quarter, Rain Oncology showed an EPS of $0.56, compared to $0.66 from the year-ago quarter. The stock has a 52-week-high of $14.48 and a 52-week-low of $1.11. At the end of the last trading period, Rain Oncology closed at $1.22.
Piper Sandler downgraded the previous rating for Rain Oncology Inc (NASDAQ:RAIN) from Overweight to Neutral. In the first quarter, Rain Oncology showed an EPS of $0.56, compared to $0.66 from the year-ago quarter. The current stock performance of Rain Oncology shows a 52-week-high of $14.48 and a 52-week-low of $1.11. Moreover, at the end of the last trading period, the closing price was at $1.22.
JMP Securities downgraded the previous rating for Greenhill & Co Inc (NYSE:GHL) from Market Outperform to Market Perform. For the first quarter, Greenhill & Co had an EPS of $1.27, compared to year-ago quarter EPS of $0.66. The current stock performance of Greenhill & Co shows a 52-week-high of $14.85 and a 52-week-low of $5.70. Moreover, at the end of the last trading period, the closing price was at $14.66.
According to Oppenheimer, the prior rating for Rain Oncology Inc (NASDAQ:RAIN) was changed from Outperform to Perform. In the first quarter, Rain Oncology showed an EPS of $0.56, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $14.48 and a 52-week-low of $1.11. Rain Oncology closed at $1.22 at the end of the last trading period.
For Rain Oncology Inc (NASDAQ:RAIN), EF Hutton downgraded the previous rating of Buy to Hold. For the first quarter, Rain Oncology had an EPS of $0.56, compared to year-ago quarter EPS of $0.66. The stock has a 52-week-high of $14.48 and a 52-week-low of $1.11. At the end of the last trading period, Rain Oncology closed at $1.22.
Credit Suisse downgraded the previous rating for VectivBio Holding AG (NASDAQ:VECT) from Outperform to Neutral. None
See all analyst ratings downgrades.
Initiations
JP Morgan initiated coverage on United States Steel Corp (NYSE:X) with a Neutral rating. The price target for United States Steel is set to $24.00. United States Steel earned $0.77 in the first quarter, compared to $3.05 in the year-ago quarter. The stock has a 52-week-high of $31.55 and a 52-week-low of $16.42. At the end of the last trading period, United States Steel closed at $21.70.
For Precigen Inc (NASDAQ:PGEN), JP Morgan initiated coverage, by setting the current rating at Neutral. In the first quarter, Precigen showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.90 and a 52-week-low of $0.81. Precigen closed at $1.31 at the end of the last trading period.
With a Buy rating, CL King initiated coverage on Silk Road Medical Inc (NASDAQ:SILK). The price target seems to have been set at $47.00 for Silk Road Medical. For the first quarter, Silk Road Medical had an EPS of $0.43, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $58.04 and a 52-week-low of $27.45. Silk Road Medical closed at $31.46 at the end of the last trading period.
JP Morgan initiated coverage on GrafTech International Ltd (NYSE:EAF) with a Neutral rating. For the first quarter, GrafTech International had an EPS of $0.02, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $9.27 and a 52-week-low of $3.75. GrafTech International closed at $4.57 at the end of the last trading period.
With a Buy rating, CL King initiated coverage on Axonics Inc (NASDAQ:AXNX). The price target seems to have been set at $75.00 for Axonics. In the first quarter, Axonics showed an EPS of $0.19, compared to $0.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $79.88 and a 52-week-low of $47.30. Axonics closed at $51.61 at the end of the last trading period.
With a Buy rating, B of A Securities initiated coverage on TopBuild Corp (NYSE:BLD). The price target seems to have been set at $225.00 for TopBuild. TopBuild earned $4.36 in the first quarter, compared to $3.50 in the year-ago quarter. The current stock performance of TopBuild shows a 52-week-high of $227.08 and a 52-week-low of $140.93. Moreover, at the end of the last trading period, the closing price was at $209.72.
JP Morgan initiated coverage on Steel Dynamics Inc (NASDAQ:STLD) with an Underweight rating. The price target for Steel Dynamics is set to $82.00. For the first quarter, Steel Dynamics had an EPS of $4.01, compared to year-ago quarter EPS of $6.02. The current stock performance of Steel Dynamics shows a 52-week-high of $136.46 and a 52-week-low of $62.44. Moreover, at the end of the last trading period, the closing price was at $97.19.
With an Underweight rating, JP Morgan initiated coverage on Nucor Corp (NYSE:NUE). The price target seems to have been set at $130.00 for Nucor. For the first quarter, Nucor had an EPS of $4.45, compared to year-ago quarter EPS of $7.67. The stock has a 52-week-high of $182.68 and a 52-week-low of $100.15. At the end of the last trading period, Nucor closed at $139.96.
With a Neutral rating, JP Morgan initiated coverage on Cleveland-Cliffs Inc (NYSE:CLF). The price target seems to have been set at $18.00 for Cleveland-Cliffs. Cleveland-Cliffs earned $0.11 in the first quarter, compared to $1.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.65 and a 52-week-low of $11.82. Cleveland-Cliffs closed at $14.87 at the end of the last trading period.
Baird initiated coverage on Chimerix Inc (NASDAQ:CMRX) with an Outperform rating. The price target for Chimerix is set to $7.00. Chimerix earned $0.24 in the first quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.89 and a 52-week-low of $1.09. Chimerix closed at $1.40 at the end of the last trading period.